Science Explorer Interactive view Map
Company · Beijing · China

Novartis (China)

In research, Novartis (China) stands highest in Life Sciences (#3,142 of 14,347 worldwide), Medicine (#5,726 of 17,978 worldwide) and Health Sciences (#7,347 of 20,462 worldwide), over all time.

novartis.comROR OpenAlex
World rank, 2022–2025
#7,129
of 28,054 · #6,976 all time
Rank in China
#1,451
of 3,058
Research works
601
▼ 9% vs 2013–17
Citations
30k
49.1 per fractional work
Top-10% rate
21.9%
record average 16.5%
Open access
46%
world 28%

What is Novartis (China) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Life SciencesDomain #3,142 of 14,347 31.9%225
MedicineField #5,726 of 17,978 25.2%241
Health SciencesDomain #7,347 of 20,462 25.2%253
Biochemistry, Genetics and Molecular BiologyField #3,091 of 7,814 32.8%153

Each strip is that field’s whole ranked pool, with the notch where Novartis (China) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.23× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.50× its world share, 21 worksBiochemistry, Geneti…Immunology and Microbiology: 6.24× its world share, 7 worksImmunology and Micro…Neuroscience: 0.85× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.59× its world share, 2 worksPharmacology, Toxico…Chemical Engineering: 0.62× its world share, 0 worksChemical EngineeringChemistry: 4.27× its world share, 8 worksChemistryComputer Science: 0.43× its world share, 4 worksComputer ScienceEnergy: 0.05× its world share, 0 worksEnergyEngineering: 0.27× its world share, 5 worksEngineeringEnvironmental Science: 0.34× its world share, 2 worksEnvironmental ScienceMaterials Science: 0.29× its world share, 1 worksMaterials ScienceMathematics: 2.54× its world share, 3 worksMathematicsPhysics and Astronomy: 0.01× its world share, 0 worksPhysics and AstronomyDentistry: 0.03× its world share, 0 worksDentistryHealth Professions: 0.32× its world share, 1 worksHealth ProfessionsMedicine: 2.12× its world share, 47 worksMedicineNursing: 0.06× its world share, 0 worksNursingVeterinary: 2.61× its world share, 0 worksVeterinaryArts and Humanities: 0.05× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.28× its world share, 1 worksBusiness, Management…Decision Sciences: 0.50× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 2.29× its world share, 6 worksEconomics, Econometr…Psychology: 0.28× its world share, 1 worksPsychologySocial Sciences: 0.16× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.2×. Every wedge is a field page.

Which keywords describe research at Novartis (China)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Clinical Trials, Quality of Life, Inflammation, Autoantibodies, Medicinal Chemistry, Gene Therapy, Drug Discovery and Genetic Variants.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology7▲ 1.51×50 topics
  2. Inflammation6▲ 2.7×31 topics
  3. Quality of Life6▲ 3.6×12 topics
  4. Clinical Trials5▲ 6.6×10 topics
  5. Cancer5▲ 3.0×22 topics
  6. Autoantibodies4▲ 13×6 topics
  7. Diagnosis4▲ 3.4×15 topics
  8. Immunotherapy3▲ 4.0×13 topics
  9. Medicinal Chemistry3▲ 10×9 topics
  10. Management3▲ 3.3×12 topics
  11. Drug Discovery3▲ 11×8 topics
  12. Gene Therapy3▲ 13×4 topics
  13. Genetic Variants3▲ 15×4 topics
  14. Monoclonal Antibodies3▲ 28×3 topics
  15. Tumor Microenvironment3▲ 5.7×7 topics
  16. Glycosylation3▲ 21×3 topics
  17. Autoimmune3▲ 47×2 topics
  18. Statins2▲ 30×2 topics
  19. Cost-effectiveness Analysis2▲ 25×1 topic
  20. Health Utility Measures2▲ 25×1 topic
  21. Innate Immunity2▲ 6.6×6 topics
  22. Breast Cancer2▲ 8.6×6 topics
  23. C-Reactive Protein2▲ 27×2 topics
  24. Cardiovascular Disease Prevention2▲ 23×2 topics
  25. Chemical Synthesis2▲ 25×2 topics
  26. Microfluidics2▲ 26×2 topics
  27. Single-Cell Analysis2▲ 35×2 topics
  28. Cholesterol-lowering2▲ 43×1 topic
  29. Continuous Flow Chemistry2▲ 51×1 topic
  30. Droplet Formation2▲ 51×1 topic
  31. Immunosuppressive Therapy2▲ 10×7 topics
  32. LDL Cholesterol2▲ 57×1 topic
  33. Therapeutic Antibodies2▲ 26×2 topics
  34. Cell Proliferation2▲ 20×4 topics
  35. Chronic Spontaneous Urticaria2▲ 81×1 topic
  36. TGF-ß2▲ 11×4 topics
  37. Urticaria2▲ 81×1 topic
  38. Antibody Engineering2▲ 31×1 topic
  39. Fc Receptors2▲ 31×1 topic
  40. Organic Synthesis2▲ 15×6 topics

Which research topics does Novartis (China) publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Lipoproteins and Cardiovascular Health, Innovative Microfluidic and Catalytic Techniques Innovation and Urticaria and Related Conditions.

Health Systems, Economic…2Health Systems, Economic Evaluations, Quality of Life: 2 fractional worksLipoproteins and Cardiov…2Lipoproteins and Cardiovascular Health: 2 fractional worksInnovative Microfluidic …2Innovative Microfluidic and Catalytic Techniques Innovation: 2 fractional worksUrticaria and Related Co…2Urticaria and Related Conditions: 2 fractional worksMonoclonal and Polyclonal Antibodies Research: 2 fractional worksClick Chemistry and Applications: 1 fractional worksPharmaceutical Economics…1Pharmaceutical Economics and Policy: 1 fractional worksComputational Drug Discovery Methods: 1 fractional worksPsoriasis: Treatment and Pathogenesis: 1 fractional worksPeptidase Inhibition and…1Peptidase Inhibition and Analysis: 1 fractional works
Economics and EconometricsSurgeryBiomedical EngineeringRheumatology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
  2. 2 Lipoproteins and Cardiovascular Health Surgery 2 works
  3. 3 Innovative Microfluidic and Catalytic Techniques Innovation Biomedical Engineering 2 works
  4. 4 Urticaria and Related Conditions Rheumatology 2 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  6. 6 Click Chemistry and Applications Organic Chemistry 1 works
  7. 7 Pharmaceutical Economics and Policy Economics and Econometrics 1 works
  8. 8 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works
  9. 9 Psoriasis: Treatment and Pathogenesis Immunology 1 works
  10. 10 Peptidase Inhibition and Analysis Oncology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.0%not open54.0%

World: 28% of research is openly available.

with international co-authors70.7%domestic only29.3%

World: 19% is written across borders.

How has Novartis (China)'s research output changed?

Output in 2018–2022 was 9% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Beijing

All research institutions in Beijing

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.